Protein Clinical Trials in Beijing, Beijing Municipality
8 recruitingBeijing, Beijing Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled618 locationsNCT07517263
Recruiting
Phase 2
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD.204 enrolled43 locationsNCT07327840
Recruiting
Phase 1Phase 2
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
Hyperlipoproteinemia (a)
Sirius Therapeutics Co., Ltd.84 enrolled1 locationNCT07172646
Recruiting
Not Applicable
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
Coronary Artery DiseaseDrug-eluting StentDual Antiplatelet Therapy+1 more
China National Center for Cardiovascular Diseases3,300 enrolled1 locationNCT06014060
Recruiting
National, Multicentric Registry Study on Neuroimmunological Diseases in China
Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Xuanwu Hospital, Beijing7,000 enrolled1 locationNCT06443333
Recruiting
China National Registry of Neuro-Inflammatory Diseases
Multiple SclerosisClinically Isolated SyndromeAcute Disseminated Encephalomyelitis+4 more
Beijing Tiantan Hospital10,000 enrolled1 locationNCT05154370
Recruiting
ctDNA Methylation for Detecting Ovarian Cancer
Circulating Tumor DNAEpithelial Ovarian CancerDNA Methylation+6 more
Lei Li1,400 enrolled1 locationNCT05801276
Recruiting
ctDNA Methylation for Epithelial Ovarian Cancer
Circulating Tumor DNAEpithelial Ovarian CancerDNA Methylation+5 more
Lei Li5,000 enrolled1 locationNCT05801263